---
title: "ABK Biomedical finished enrolling in ROUTE90 trial for liver cancer. Final patient treated in FDA study for HCC. 104 characters."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276751616.md"
description: "The last participant has received treatment in a Food and Drug Administration Investigational Device Exemption (FDA IDE) study investigating the efficacy of Eye90 microspheres® in managing unresectable Hepatocellular Carcinoma (HCC). This significant development occurred in Halifax, NS on February 24, 2026. ABK Biomedical, Inc., a pioneering medical device business committed to advancing the treatment landscape, led the study."
datetime: "2026-02-24T14:16:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276751616.md)
  - [en](https://longbridge.com/en/news/276751616.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276751616.md)
generator: "portal-rs"
---

# ABK Biomedical finished enrolling in ROUTE90 trial for liver cancer. Final patient treated in FDA study for HCC. 104 characters.

The last participant has received treatment in a Food and Drug Administration Investigational Device Exemption (FDA IDE) study investigating the efficacy of Eye90 microspheres® in managing unresectable Hepatocellular Carcinoma (HCC). This significant development occurred in Halifax, NS on February 24, 2026. ABK Biomedical, Inc., a pioneering medical device business committed to advancing the treatment landscape, led the study.

### Related Stocks

- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [CLSDQ.US](https://longbridge.com/en/quote/CLSDQ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [Koala trial doses first patient with novel KMA‑targeting CAR‑T](https://longbridge.com/en/news/298021066.md)
- [Grupa Azoty announces extraordinary shareholder meeting](https://longbridge.com/en/news/297635728.md)
- [“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z](https://longbridge.com/en/news/297407072.md)
- [EverGen Infrastructure Reports Q2 2026 Results | EVGIF Stock News](https://longbridge.com/en/news/297122882.md)
- [Moderna surges on trial win for cancer shot; William Blair upgrades](https://longbridge.com/en/news/296370751.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**